Literature DB >> 12748901

[Persistent polyclonal B-cell lymphocytosis].

U Schönermarck1, H Diem, P Lohse, W Samtleben.   

Abstract

HISTORY AND CLINICAL
FINDINGS: A 54-year-old woman was referred for ambulant checkup after an episode of acute renal failure due to severe gastroenteritis and recurrent arthralgias. Physical examination was unremarkable except for the presence of palpable small cervical lymph nodes. INVESTIGATIONS: Serum IgM levels showed a polyclonal increase. All the other routinely examined parameters were within normal limits. Microscopical blood smear examination revealed binucleated lymphocytes. Immunophenotyping of peripheral blood showed a polyclonal B-cell lymphocytosis despite normal numbers of leukocytes and lymphocytes. PCR analysis identified cells with a t(14;18) translocation (bcl-2/IgH rearrangement). DIAGNOSIS: A routine medical checkup disclosed the diagnosis of persistent polyclonal B-cell lymphocytosis. This rare benign lymphoproliferative disorder is characterized by binucleated lymphocytes, polyclonal expansion of B-cells, and a polyclonal increase in serum IgM. The diagnosis was established despite the lack of leukocytosis or lymphocytosis in the peripheral blood.
CONCLUSIONS: Because of its benign and indolent course without the need for chemotherapy, it is important to discriminate the disorder of persistent polyclonal B-cell lymphocytosis from other malignant lymphoproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748901     DOI: 10.1055/s-2003-39254

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  [Incidental finding lymphocytosis. From normal variants up to leukemia].

Authors:  K-A Kreuzer; M Hallek
Journal:  Internist (Berl)       Date:  2014-10       Impact factor: 0.743

2.  [Asymptomatic 32 year old female smoker with persistent polyclonal lymphocytosis].

Authors:  B Chapuy; G Wulf; H W Tessen; F Griesinger; L Trümper; R Schroers
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.